Speaker illustration

Doctor Markus Samuel Ritvos

Helsinki University Hospital, Helsinki (Finland)

Member of:

European Society of Cardiology

CYP2C19 loss-of-function alleles and the use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel - a real-world study

Event: ESC Congress 2022

Topic: Pharmacogenetics

Session: Short and long-term antiplatelet therapy in clinical practice

Thumbnail

This platform is supported by

logo Novo Nordisk